David Hung

NUVB

David Hung serves as PRESIDENT AND CEO at Nuvation Bio Inc. (NUVB). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$1.71M

Total Sells

1 trades

$17.3K

Net Position

Net Buyer

$1.70M

Companies Traded

NUVB, NVCR

Active Period

Apr 2025 – Jun 2025

3 total trades

Most Recent

Buy NUVB

Jun 16, 2025 · $893.5K

David Hung's Insider Trading at Nuvation Bio Inc. (NUVB)

Buys

2 · $1.71M

Sells

0 · $0.00

Total Shares Bought

1,000,000

Total Shares Sold

NUVB Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jun 16, 2025	Buy	500,000	$1.79	$893.5K	0
Apr 4, 2025	Buy	500,000	$1.64	$820.2K	0

David Hung's Insider Trading at NovoCure Limited (NVCR)

Buys

0 · $0.00

Sells

1 · $17.3K

Total Shares Bought

Total Shares Sold

999

NVCR Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jun 3, 2025	Sell	999	$17.30	$17.3K	0

Related Insiders

Kerry Wentworth

officer: CHIEF REGULATORY OFFICER

NUVBSell · Apr 21, 2026

Dongfang Liu

officer: CHIEF MEDICAL OFFICER

NUVBSell · Apr 21, 2026

Mukund Paravasthu

Chief Operating Officer

NVCRSell · Jan 11, 2026

Gary Hattersley

CHIEF SCIENTIFIC OFFICER

NUVBSell · Nov 20, 2025

David C. Hanley

CHIEF TECHNICAL OPERATIONS

NUVBSell · Nov 19, 2025

Christoph Brackmann

Chief Financial Officer

NVCRSell · Nov 4, 2025

Frank X Leonard

EVP, Pres., Novocure Oncology

NVCRSell · Nov 1, 2025

Michal Nath Puri

Chief Human Resources Officer

NVCRSell · Oct 31, 2025

Explore More Insider Trading Data

NUVB Insider Trading Activity

View all insider trades at Nuvation Bio Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity